Contribution to a book

DZNE-2025-00183

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine

Adelaja Osibote, O. (Editor) ; Eppard, E. (Editor) ; Vahidfar, N. ; Bakhshi Kashi, M. ; Afshar, S. ; Sheikhzadeh, P. ; Farzanefar, S. ; Salehi, Y. ; Delpasand, E. ; Molloy, E. N.DZNE* ; Mirzaei, S. ; Ahmadzadehfar, H. ; Eppard, E.

2024
IntechOpen

This record in other databases:

Please use a persistent id in citations: doi:10.5772/intechopen.1003993

Abstract: Copper radioisotopes including copper-60/61/62, and -64 exhibit a wide range of decay characteristics, making them appropriate choices for diagnostic/therapeutic (theranostic) applications in nuclear medicine. One notable feature of copper is the feasible coordination chemistry, which makes radiolabeling of a wide range of chemical structures including antibodies, proteins, peptides, and other biologically relevant small molecules possible. This chapter will summarize common radiopharmaceuticals of copper-64 and their radiation dosimetry in order to highlight recent improvements of positron emission tomography diagnostics.

---

Contributing Institute(s):

1. Multimodal Neuroimaging (AG Maaß)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

---

Database coverage:
;

---